Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$13.95
-0.06-0.43%
At close: -
$13.76
-0.19-1.36%
After Hours: 9:30 AM EDT
Comments
Loading...
Indivior (INDV) Forecast
NewsEarningsIndivior (INDV) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Indivior Stock Price, Quotes and Forecasts | NASDAQ:INDV | Benzinga
Explore Indivior stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for INDV.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Indivior (INDV) stock?
You can purchase shares of Indivior (NASDAQ:INDV) through any online brokerage.
Who are Indivior (INDV) competitors?
Other companies in Indivior’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), WAVE Life Sciences (NASDAQ:WVE), Tarsus Pharmaceuticals (NASDAQ:TARS), ANI Pharmaceuticals (NASDAQ:ANIP) and Axsome Therapeutics (NASDAQ:AXSM).
What is the forecast, or price target, for Indivior (INDV) stock?
Indivior has a consensus price target of $14.50.
What is the current price for Indivior (INDV)?
The stock price for Indivior (NASDAQ: INDV) is $13.76 last updated June 23, 2025 at 9:30 AM EDT.
Does Indivior (INDV) pay a dividend?
There are no upcoming dividends for Indivior.
When is Indivior (NASDAQ:INDV) reporting earnings?
Indivior’s Q2 earnings are confirmed for Thursday, July 24, 2025.
Is Indivior (INDV) going to split?
There is no upcoming split for Indivior.
What sector and industry does Indivior (INDV) operate in?
Indivior is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
